<DOC>
	<DOCNO>NCT00184665</DOCNO>
	<brief_summary>This trial conduct Africa , Asia , Europe , Oceania , South America . The aim research study compare efficacy ( reduction HbA1c blood glucose level ) insulin detemir compare NPH insulin administer basal insulin treatment type 1 diabetes verify safety use ( number severity episodes hypoglycemia , body weight , insulin antibody side effect ) .</brief_summary>
	<brief_title>Comparison Insulin Detemir With NPH Insulin Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 1 diabetes Currently basalbolus regimen BMI = 35.0 kg/m2 HbA1c =11.0 % Proliferative retinopathy maculopathy Recurrent major hypoglycaemia Cardial problem Uncontrolled hypertension Impaired hepatic renal function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>